This report summarizes the findings from a global post-eradication inactivated polio vaccine (IPV) supply and demand assessment conducted from 2007 to 2008. The goal of the study was to inform ongoing IPV discussions and potential policy development …

The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World Health Assembly in May 2012—is a roadmap to prevent millions of deaths by 2020 through more equitable access to vaccines for people in all communities. …

This document outlines the steps and process involved with developing a comprehensive multi-year plan for national immunization programs.

Targeted at immunization service managers, logisticians, policymakers, researchers, international donors, and health planners in developing countries, these WHO guidelines outline a stepped approach for estimating the incremental costs of …

WHO developed these guidelines to present a method for determining the costs associated with diarrheal disease in children under 5 years of age.

This study, published in The Journal of Infectious Diseases, estimated economic burden and the vaccination cost-effectiveness ratio to determine potential reductions in health care costs associated with rotavirus-specific diarrhea.

This report addresses issues related to financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms, which will constitute some of the most significant challenges to achieving widespread HPV …

This monograph, published in Vaccine, summarizes the present state of human papillomavirus vaccines and screening in the prevention of cervical cancer. It provides a number of articles covering epidemiological achievements, technical developments, …

This web page is an online resource for information and data about immunization financing in low- and lower-middle-income countries. In November 2008, several new features were added including: country profiles with a summary of …

These user-friendly briefing sheets, prepared by the World Bank and intended for policymakers in Ministries of Health, Finance, Planning and Investment, outline options for financing national immunization services.

An overview of immunization support to developing countries provided through the GAVI Alliance.

Financing is a critical component of a sustainable immunization program. This toolkit is comprised of a series of short briefs on different options for financing national immunization programs and vaccines. It is intended to serve as a resource for …

This report summarizes the results of a six-month inquiry by the UK All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World (APPG) on the global disease burden of pneumococcal disease and pneumonia, …

This fact sheet explores different incentives and innovative financing mechanisms and their role in the development of global health products, including vaccines. In addition to providing an overview of the different options available, it also …

This article, published in Vaccine, describes a study that estimated the incremental costs of transitioning from needles and syringes to delivering childhood vaccines with disposable-syringe jet injectors (DSJIs) in Brazil, India, and South Africa. …

In this commentary from the journal The Lancet, the authors encourage support for creative approaches to financing global health initiatives, including a 2006 airline tax adopted by France, advance market commitments for new vaccines, and the …

General information on the function and objectives of IFFIm, a new funding mechanism that secures pledges of future aid in order to leverage money from international capital markets to support national immunization programmes.

This web page brings together resources useful to address policy and programmatic aspects of introducing a new vaccine. It may be used as a reference for decision-making and implementation by country-level policymakers, national immunization program …

This paper, published in Vaccine, examines five ways of reducing the time between the license of a vaccine into the developed world and the developing world. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to …

This brochure describes the Global Immunization Vision and Strategy (GIVS), which aims to protect more people against more diseases. It describes achievements in childhood immunization and the benefits of this key and cost-effective health …

This commentary discusses the barrier of vaccine price on sustainable immunization programs in developing countries and offers examples of new mechanisms driven by public-private partnerships to overcome issues of affordability.

This fact sheet on investing in vaccines for the developing world details the cost of developing and distributing vaccines, and it outlines the innovative funding solutions designed to address these issues.

This article, published in Vaccine, provides preliminary evidence on the potential outcome of the pneumococcal vaccine Advance Market Commitment, with a focus on its impact on innovation in emerging vaccine manufacturers in low-resource countries. …

This strategic plan, prepared by PATH from the contributions of 17 partner organizations, provides details on priority activities that must be sustained for continued momentum in Japanese encephalitis (JE) control, including improved …

This white paper provides an analysis of supply-side constraints and demand-side determinants of routine immunization coverage in Nigeria. It emphasizes that tackling the basic barriers to routine immunization in Nigeria—cold chain, transport, …